Compile Data Set for Download or QSAR
maximum 50k data
Found 75 with Last Name = 'tsujii' and Initial = 's'
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM50222709(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-N-(2-h...)
Affinity DataIC50:  2nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US PatentMMDB

TargetBeta-1/Beta-2/Beta-3 adrenergic receptor(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM25764(ALPRENOLOL,(+) | ALPRENOLOL,(-) | Alfeprol | Alphe...)
Affinity DataIC50:  2.30nMAssay Description:Compound was evaluated for its Beta adrenergic receptor blocking actionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetBeta-1/Beta-2/Beta-3 adrenergic receptor(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218691(CHEMBL51667)
Affinity DataIC50:  4.30nMAssay Description:Compound was evaluated for its Beta adrenergic receptor blocking actionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104963(CHEMBL507361 | US11147816, PD0325901 | US11701360,...)
Affinity DataIC50:  5.20nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104959(US8575391, G-2)
Affinity DataIC50:  7.20nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104951(US8575391, F-2)
Affinity DataIC50:  8.60nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM50338038(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-N-(2-h...)
Affinity DataIC50:  8.80nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104949(US8575391, C-31)
Affinity DataIC50:  12nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104939(US8575391, B-9)
Affinity DataIC50:  15nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104945(US8575391, C-10)
Affinity DataIC50:  19nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104941(US8575391, C-1)
Affinity DataIC50:  19nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104936(US8575391, B-1)
Affinity DataIC50:  21nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104938(US8575391, B-6)
Affinity DataIC50:  23nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104946(US8575391, C-13)
Affinity DataIC50:  28nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104955(US8575391, F-6)
Affinity DataIC50:  28nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104952(US8575391, F-3)
Affinity DataIC50:  29nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104940(US8575391, B-12)
Affinity DataIC50:  31nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104944(US8575391, C-8)
Affinity DataIC50:  32nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104937(US8575391, B-2)
Affinity DataIC50:  32nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104953(US8575391, F-4)
Affinity DataIC50:  35nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104950(US8575391, F-1)
Affinity DataIC50:  35nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104960(US8575391, G-3)
Affinity DataIC50:  37nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104962(US8575391, G-5)
Affinity DataIC50:  40nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104954(US8575391, F-5)
Affinity DataIC50:  43nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104956(US8575391, F-7)
Affinity DataIC50:  48nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104942(US8575391, C-6)
Affinity DataIC50:  49nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104961(US8575391, G-4)
Affinity DataIC50:  56nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104957(US8575391, F-8)
Affinity DataIC50:  65nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104947(US8575391, C-24)
Affinity DataIC50:  68nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104948(US8575391, C-28)
Affinity DataIC50:  68nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104958(US8575391, F-9)
Affinity DataIC50:  70nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1/Beta-2/Beta-3 adrenergic receptor(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM96235(4-[2-hydroxy-3-(isopropylamino)propoxy]-3-methyl-c...)
Affinity DataIC50:  98nMAssay Description:Compound was evaluated for its Beta adrenergic receptor blocking actionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50101969(3-Methyl-4-{3-[(pyridin-3-ylmethyl)-amino]-propoxy...)
Affinity DataIC50:  100nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM50132260(2-(2-Chloro-4-iodo-phenylamino)-N-cyclopropylmetho...)
Affinity DataIC50:  130nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDual specificity mitogen-activated protein kinase kinase 1(Homo sapiens (Human))
Chugai Seiyaku Kabushiki Kaisha

US Patent
LigandPNGBDBM104943(US8575391, C-7)
Affinity DataIC50:  140nMAssay Description:Inhibition assay using MEK kinase.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50034993((S)-6-Amino-2-[(S)-3-hydroxy-2-(2-{4-[4-(2-methyl-...)
Affinity DataIC50:  830nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM96235(4-[2-hydroxy-3-(isopropylamino)propoxy]-3-methyl-c...)
Affinity DataIC50:  980nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218691(CHEMBL51667)
Affinity DataIC50:  1.20E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218690(CHEMBL53026)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50101968(4-(3-tert-Butylamino-propoxy)-3-methyl-benzofuran-...)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218696(CHEMBL299034)
Affinity DataIC50:  3.30E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218743(CHEMBL53246)
Affinity DataIC50:  4.40E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218688(CHEMBL416300)
Affinity DataIC50:  4.40E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218744(CHEMBL53257)
Affinity DataIC50:  4.40E+3nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218692(CHEMBL52631)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218694(CHEMBL52854)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1/Beta-2/Beta-3 adrenergic receptor(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50101968(4-(3-tert-Butylamino-propoxy)-3-methyl-benzofuran-...)
Affinity DataIC50:  2.50E+4nMAssay Description:Compound was evaluated for its Beta adrenergic receptor blocking actionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-1/Beta-2/Beta-3 adrenergic receptor(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218688(CHEMBL416300)
Affinity DataIC50:  3.80E+4nMAssay Description:In vitro ability of the compound to displace radiolabelled FTI from farnesyltransferase in cultured Ha-ras transformed RAT1 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218699(CHEMBL55282)
Affinity DataIC50:  5.00E+4nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycylpeptide N-tetradecanoyltransferase 1/2(Homo sapiens (Human))
Nippon Roche Research Center

Curated by ChEMBL
LigandPNGBDBM50218697(CHEMBL51868)
Affinity DataIC50:  7.90E+4nMAssay Description:Inhibitory activity against Candida albicans N-myristoyltransferase (CaNmt)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 75 total ) | Next | Last >>
Jump to: